Search research articles
Contact Us
Filters
Showing results (701-710 of 710) with videos related to
Page
of 71
Sort By:
You have reached the last page of results.
This site can display upto 710 results.
BMJ Open
|
December 7, 2024
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial
Ki Hong Choi, Juwon Kim, Danbee Kang, et al.
Lancet (London, England)
|
April 2, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Ki Hong Choi, Yong Hwan Park, Jong-Young Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2022
Endometrial carcinosarcoma
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
JACC. Cardiovascular Interventions
|
December 21, 2024
Clinical Relevance of Discordance Between Physiology- and Imaging-Guided PCI Strategies in Intermediate Coronary Stenosis
Jinlong Zhang, Wei Yu, Xinyang Hu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 14, 2026
Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial
Hyo-Suk Ahn, Jeong-Cheon Ahn, Jin-Man Cho, et al.
Lancet (London, England)
|
June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Alexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
The New England Journal of Medicine
|
March 30, 2026
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction
Ki Hong Choi, Danbee Kang, Weon Kim, et al.
The Lancet. Oncology
|
July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Stefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Clinical Therapeutics
|
May 4, 2024
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy
Hae-Young Lee, Kyung Wan Min, Kyung Ah Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Page
of 71
Search research articles
Search
Showing results (701-710 of 710) with videos related to
Sort By:
Page
of 71
You have reached the last page of results.
This site can display upto 710 results.
BMJ Open
|
December 7, 2024
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial
Ki Hong Choi, Juwon Kim, Danbee Kang, et al.
Lancet (London, England)
|
April 2, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Ki Hong Choi, Yong Hwan Park, Jong-Young Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2022
Endometrial carcinosarcoma
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
JACC. Cardiovascular Interventions
|
December 21, 2024
Clinical Relevance of Discordance Between Physiology- and Imaging-Guided PCI Strategies in Intermediate Coronary Stenosis
Jinlong Zhang, Wei Yu, Xinyang Hu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 14, 2026
Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial
Hyo-Suk Ahn, Jeong-Cheon Ahn, Jin-Man Cho, et al.
Lancet (London, England)
|
June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Alexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
The New England Journal of Medicine
|
March 30, 2026
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction
Ki Hong Choi, Danbee Kang, Weon Kim, et al.
The Lancet. Oncology
|
July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Stefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Clinical Therapeutics
|
May 4, 2024
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy
Hae-Young Lee, Kyung Wan Min, Kyung Ah Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Page
of 71